Vidéos
See all our videos
News

  • 28/01/2013

    Cellvizio featured in 9news.com : World's smallest microscope finds cancer faster

    St. Anthony Hospital is the first hospital in Colorado to use the new advanced-imaging technology, called Cellvizio, with at-risk patients during standard endoscopy and colonoscopy procedures as well as the pancreatic and bile duct cancer detection procedure. Cellvizio allows physicians to view internal tissues cell-by-cell to pinpoint cancerous and pre-cancerous tissue more efficiently than current procedures. Dr. Matt Reveille says the new technology helps doctors respond once they identify dangerous tissue.
    more

  • 26/11/2012

    Cellvizio in the Sioux Falls Business Journal

    Fantastic article by Sanford Hospital in the Sioux Falls Business Journal. "This can change the practice of medicine,” said Dr. Muslim Atiq, a gastroenterologist at Sanford. “The whole key is to find cancer before cancer occurs. To find it very early makes a big difference.”
    more
See all news
Events

  • 29/11/2013

    Endo-Update

    Endo-update 2013 is a two-day interventional endoscopy update course in Augsburg, Germany, with an internationally recognized faculty highlighting the latest research, skills, and technologies with simultaneous live sessions, state-of-the-art lectures, case discussions and interactive case presentations. More details to come soon !
    more
See all events
Training

  • 17/06/2013

    CELLVIZIO DAY : TRAINING WORKSHOP AT PAOLI CALMETTES INSTITUTE - MARSEILLE, FRANCE

    Acquire a basic understanding of how the Cellvizio system works, and learn how to interpret Cellvizio images of the esophagus, bile duc and colon. Live cases will be observed and the latest clinical data and case studies will be analyzed.
See all training opportunities
Newsletter

  • 07/05/2013

    Cellvizio News, May 2013

    FDA grants Mauna Kea Technologies 510(k) clearance to market AQ-Flex™19 miniprobe for fine needle aspiration procedures Mauna Kea Technologies announced that the U.S. Food and Drug Administration (FDA) has cleared the AQ‐Flex™ 19 miniprobe to provide real‐time optical biopsies during endoscopic ultrasound‐guided fine needle aspiration (EUSFNA) procedures in the digestive tract. This represents the sixth U.S. regulatory clearance for Mauna Kea Technologies’ Cellvizio on one of its dedicated miniprobes, which already obtained the CE mark in Europe.
    more
See all newsletters

Contact us Français / English International Version | Go to the US Version